Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer (Q27853334)

26838030

13 November 2016

title

Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer (English)

1 reference

13 November 2016

1 reference

Yan Qiao

1

0 references

Xi Zhu

2

0 references

Aiwei Li

3

0 references

Shuo Yang

4

0 references

Jie Zhang

Global cancer statistics, 2012

5

0 references

publication date

August 2016

0 references

published in

Tumor Biology

0 references

volume

37

0 references

issue

8

0 references

page(s)

10279-86

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Cancer treatment and survivorship statistics, 2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Cohesin in cancer: chromosome segregation and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Differential regulation of telomere and centromere cohesion by the Scc3 homologues SA1 and SA2, respectively, in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Dissociation of cohesin from chromosome arms and loss of arm cohesion during early mitosis depends on phosphorylation of SA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Specific sites in the C terminus of CTCF interact with the SA2 subunit of the cohesin complex and are required for cohesin-dependent insulation activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Frequent truncating mutations of STAG2 in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Mutational inactivation of STAG2 causes aneuploidy in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

STAG2 promotes error correction in mitosis by regulating kinetochore-microtubule attachments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

Evidence of a transcriptional co-activator function of cohesin STAG/SA/Scc3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4894-4

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/26838030

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Annual report on status of cancer in China, 2011

1 reference

https://pubmed.ncbi.nlm.nih.gov/26838030

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-016-4894-4

0 references

Dimensions Publication ID

1047774529

0 references

26838030

1 reference

26838030